Remarkable Case: German Receives COVID-19 Vaccine 217 Times
Doctors report an unusual case involving a 62-year-old man from Germany who received 217 Covid vaccinations against medical advice
HOT: » Assessing the Legacy of Bulgaria's "Denkov" Cabinet: Achievements, Failures, and What Comes Next
European Medical Agency safety committee (PRAC) concluded that a warning about unusual blood clots with low blood platelets should be added to the product information for COVID-19 Vaccine Janssen. PRAC also concluded that these events should be listed as very rare side effects of the vaccine.
In reaching its conclusion, the Committee took into consideration all currently available evidence including eight reports from the United States of serious cases of unusual blood clots associated with low levels of blood platelets, one of which had a fatal outcome. As of 13 April 2021, over 7 million people had received Janssen’s vaccine in the United States.
All cases occurred in people under 60 years of age within three weeks after vaccination, the majority in women. Based on the currently available evidence, specific risk factors have not been confirmed.
PRAC noted that the blood clots occurred mostly at unusual sites such as in veins in the brain (cerebral venous sinus thrombosis, CVST) and the abdomen (splanchnic vein thrombosis) and in arteries, together with low levels of blood platelets and sometimes bleeding. The cases reviewed were very similar to the cases that occurred with the COVID-19 vaccine developed by AstraZeneca, Vaxzevria.
Healthcare professionals and people who will receive the vaccine should be aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within three weeks of vaccination.
COVID-19 is associated with a risk of hospitalisation and death. The reported combination of blood clots and low blood platelets is very rare, and the overall benefits of COVID-19 Vaccine Janssen in preventing COVID-19 outweigh the risks of side effects.
EMA’s scientific assessment underpins the safe and effective use of COVID-19 vaccines. Use of the vaccine during vaccination campaigns at national level will take into account the pandemic situation and vaccine availability in individual Member States.
One plausible explanation for the combination of blood clots and low blood platelets is an immune response, leading to a condition similar to one seen sometimes in patients treated with heparin called heparin induced thrombocytopenia, or HIT.
EMA will continue to monitor the vaccine’s safety and effectiveness and provide the public with the latest information.
We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!
Despite notable progress in reducing infant mortality rates, Bulgaria continues to grapple with figures well above the European Union average
Recent research conducted by the ecological association "For the Earth" has shed light on concerning levels of nitrogen dioxide pollution in Sofia
Recent measurements conducted by a team of experts, led by renowned air quality specialist Dr. Axel Friedrich, have revealed alarming levels of nitrogen dioxide pollution in Sofia
Speech therapists from Varna note an increasing prevalence of issues concerning children's speech development in recent times, BNT reported
Doctors report an unusual case involving a 62-year-old man from Germany who received 217 Covid vaccinations against medical advice
Bulgaria is facing a concerning trend as new data reveals that every third child in the country is overweight, with obesity rates soaring among adolescents
Norwegian Inspiration: Bulgaria's Move Towards Environmentally Friendly Prisons
Nexo Is Suing Bulgaria For Over $3 Billion